PULVIRENTI, LUANA
 Distribuzione geografica
Continente #
NA - Nord America 355
EU - Europa 270
AS - Asia 71
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 748
Nazione #
US - Stati Uniti d'America 349
IT - Italia 128
IE - Irlanda 60
CN - Cina 59
CI - Costa d'Avorio 27
SN - Senegal 22
RU - Federazione Russa 16
BE - Belgio 14
DE - Germania 14
UA - Ucraina 14
GB - Regno Unito 7
CA - Canada 5
SE - Svezia 5
CZ - Repubblica Ceca 4
HU - Ungheria 4
TR - Turchia 4
UZ - Uzbekistan 3
IN - India 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
EU - Europa 1
FR - Francia 1
LB - Libano 1
PL - Polonia 1
PR - Porto Rico 1
PT - Portogallo 1
SA - Arabia Saudita 1
SG - Singapore 1
Totale 748
Città #
Chandler 129
Dublin 60
Catania 28
Abidjan 27
Ashburn 24
Dakar 22
Andover 15
Cambridge 15
Lawrence 15
Brussels 14
Nanjing 11
Boardman 10
Des Moines 9
Jacksonville 9
Tianjin 9
Bremen 6
Turin 6
Padova 5
Saint Petersburg 5
Toronto 5
Beijing 4
Los Angeles 4
Marina di Ravenna 4
San Mateo 4
Wilmington 4
Amantea 3
Fairfield 3
Hebei 3
Jinan 3
Licata 3
Messina 3
Milan 3
Nanchang 3
Palermo 3
Pécs 3
San Francisco 3
Shenyang 3
Washington 3
Acquaviva delle Fonti 2
Assago 2
Brno 2
Cagliari 2
Caserta 2
Changsha 2
Gravina di Catania 2
Jiaxing 2
Konya 2
Linfen 2
Liverpool 2
Ningbo 2
Providence 2
Pune 2
Seattle 2
Taizhou 2
Verona 2
Aci Sant'Antonio 1
Ann Arbor 1
Biancavilla 1
Budapest 1
Caltanissetta 1
Casavatore 1
Dallas 1
Foiano della Chiana 1
Frankfurt am Main 1
Fuzhou 1
Grafing 1
Lisbon 1
Manchester 1
Melbourne 1
Mountain View 1
Norwalk 1
Prague 1
Redwood City 1
Riyadh 1
Rome 1
Salerno 1
San Jose 1
San Juan 1
Sant'Agata di Militello 1
Shanghai 1
Singapore 1
Stuttgart 1
Taormina 1
Zhengzhou 1
Totale 546
Nome #
Bioinspired benzoxanthene lignans as a new class of antimycotic agents: synthesis and Candida spp. growth inhibition 70
2,3-Dihydrobenzofuran neolignans: biomimetic synthesis and biological properties 60
Bioinspired neolignans: chemo-enzymatic synthesis and antiproliferative activity 53
How do sowing time and plant density affect the pigments safflomins and carthamin in florets of safflower? 53
Ellagitannins and gallotannins as -amylase and -glucosidase inhibitors in type 2 diabetes 52
The double effect of walnut septum extract (Juglans regia L.) counteracts A172 glioblastoma cell survival and bacterial growth 52
C-glucosidic ellagitannins and galloylated glucoses as potential functional food ingredients with anti-diabetic properties: a study of α-glucosidase and α-amylase inhibition 50
Sintesi chemo-enzimatica di neolignani correlate al magnololo e studio dell’attività di inibizione dell’α-glucosidasi 49
Sintesi e proprietà biologiche di neolignani ispirati al magnololo 48
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors 43
Studio di tannini idrolizzabili quali potenziali agenti antidiabetici 40
Chemo-Enzymatic Synthesis and Selective Hydroxylation of Dimeric Neolignans Inspired by Magnolol 38
Chain-breaking antioxidant activity of hydroxylated and methoxylated magnolol derivatives: the role of H-bonds 38
Synthesis, DNA/RNA-interaction and biological activity of benzo[k,l]xanthene lignans 37
Identification by Inverse Virtual Screening of magnolol-based scaffold as new tankyrase-2 inhibitors 36
Influence of the rootstock and the environment on qualitative traits and phenolic composition in blood oranges 31
An integrated approach for the characterization of wild Crocus species adopting phenotypical and phytochemical traits 26
Evaluation of honokiol, magnolol and of a library of new nitrogenated neolignans as pancreatic lipase inhibitors 18
Lipase inhibitory analysis of magnolol, honokiol and three nitrogenated derivatives 12
Synthesis of bioactive neolignan obovatol and analogues as hypoglicemic agents 6
NATURAL OR BIO-INSPIRED POLYPHENOLS IN THE SYNTHESIS OF POTENTIAL CHEMOTHERAPEUTIC AGENTS 4
Evaluation of obovatol and of a small library of analogues as hypoglycemic agents 4
Bioactive neolignans magnolol, honokiol and obovatol and their synthetic analogues as digestive enzyme inhibitors 3
Antiandrogenic activity and bioavailability of magnolol analogs – A potential for prostate cancer therapeutics 2
Magnolol derivatives as specific and noncytotoxic inhibitors of breast cancer resistance protein (BCRP/ABCG2) 1
Totale 826
Categoria #
all - tutte 3.054
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.054


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201926 0 0 0 0 0 0 0 0 0 0 18 8
2019/202070 21 8 1 0 1 0 9 0 20 2 5 3
2020/202174 5 3 9 8 21 3 5 1 14 0 2 3
2021/2022114 4 16 2 1 24 2 19 3 5 0 6 32
2022/2023361 16 32 8 38 29 47 5 64 85 10 19 8
2023/2024151 8 43 20 10 6 27 5 16 2 7 7 0
Totale 826